Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

411
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
411
Abnormal Proliferation02:23

Abnormal Proliferation

5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
Antigens Involved in Adaptive Immunity01:26

Antigens Involved in Adaptive Immunity

1.3K
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
1.3K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

6.5K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
6.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Extrahepatic manifestations of hepatitis B virus infection: Addison's disease and myelofibrosis in a patient with persistent hepatitis B surface antigenemia.

The Canadian journal of infectious diseases = Journal canadien des maladies infectieuses·2012
Same author

Methyldopa-induced thrombocytopenia.

Canadian Medical Association journal·2010
Same author

Pulse oximetry in sickle cell disease.

Archives of disease in childhood·1993
Same author

Accumulation of high levels of methotrexate polyglutamates in lymphoblasts from children with hyperdiploid (greater than 50 chromosomes) B-lineage acute lymphoblastic leukemia: a Pediatric Oncology Group study.

Blood·1992
Same author

Sickle cell disease in a patient with sickle cell trait and compound heterozygosity for hemoglobin S and hemoglobin Quebec-Chori.

The New England journal of medicine·1991
Same author

Ventilation and gas exchange during exercise in sickle cell anemia.

The American review of respiratory disease·1991
Same journal

Toward exercise as standard care for older cancer survivors.

Cancer·2026
Same journal

Maintenance therapy in gynecologic malignancies: Current and future state.

Cancer·2026
Same journal

Long-term outcomes of evolving treatment regimens in Ewing sarcoma survivors diagnosed 1970-1999: A report from the Childhood Cancer Survivor Study.

Cancer·2026
Same journal

Large-scale osteosarcoma sequencing reveals age-associated genomic architectures.

Cancer·2026
Same journal

EZH2 inhibitor tazemetostat voluntarily withdrawn from market.

Cancer·2026
Same journal

Nivolumab and chemotherapy combination approved for previously untreated Hodgkin lymphoma.

Cancer·2026
See all related articles

Related Experiment Video

Updated: Jan 17, 2026

Author Spotlight: Advancing the Detection of Low-Frequency Mutations in Cancer Tissues
07:17

Author Spotlight: Advancing the Detection of Low-Frequency Mutations in Cancer Tissues

Published on: August 23, 2024

1.8K

Malignant histiocytosis.

D W Esseltine, N K De Leeuw, G R Berry

    Cancer
    |November 15, 1983
    PubMed
    Summary
    This summary is machine-generated.

    Malignant histiocytosis (MH) treatment may benefit from combination chemotherapy. Patient organ dysfunction scores can predict survival and chemotherapy response, highlighting a need for better characterization of malignant cells.

    More Related Videos

    Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
    08:57

    Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors

    Published on: May 17, 2024

    2.5K
    Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts
    07:18

    Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts

    Published on: June 13, 2019

    7.4K

    Related Experiment Videos

    Last Updated: Jan 17, 2026

    Author Spotlight: Advancing the Detection of Low-Frequency Mutations in Cancer Tissues
    07:17

    Author Spotlight: Advancing the Detection of Low-Frequency Mutations in Cancer Tissues

    Published on: August 23, 2024

    1.8K
    Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
    08:57

    Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors

    Published on: May 17, 2024

    2.5K
    Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts
    07:18

    Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts

    Published on: June 13, 2019

    7.4K

    Area of Science:

    • Hematology
    • Oncology
    • Pathology

    Background:

    • Malignant histiocytosis (MH) is a rare neoplastic disorder.
    • Understanding clinical features and treatment outcomes is crucial for patient management.

    Purpose of the Study:

    • To present clinical features, therapy, and hospital course of ten consecutive malignant histiocytosis patients.
    • To evaluate the diagnostic value of bone marrow aspiration in MH.
    • To explore the predictive value of organ dysfunction scores for survival and chemotherapy response.

    Main Methods:

    • Retrospective review of ten consecutive malignant histiocytosis cases.
    • Analysis of clinical data, including performance status and organ dysfunction scores.
    • Review of existing literature on chemotherapy for malignant histiocytosis.

    Main Results:

    • Bone marrow aspiration is a valuable diagnostic tool for malignant histiocytosis.
    • Organ dysfunction scores may predict patient survival and response to chemotherapy.
    • Combination chemotherapy appears to be the preferred treatment approach, with limited data on single agents.

    Conclusions:

    • Further research is needed for better characterization of the malignant cell in malignant histiocytosis.
    • Combination chemotherapy warrants further investigation as a primary treatment strategy.
    • Organ dysfunction scores can aid in prognostication and treatment planning for MH patients.